Company Filing History:
Years Active: 2022-2025
Title: Lian Willetts: Innovator in Cancer Treatment
Introduction
Lian Willetts is a prominent inventor based in Edmonton, Canada. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of metastatic cancer. With a total of 2 patents to her name, Willetts is recognized for her innovative approaches to complex medical challenges.
Latest Patents
Willetts' latest patents focus on methods for diagnosing and treating metastatic cancer. These patents disclose methods that involve detecting or modulating the expression of various genes and microRNAs in biological samples from subjects. The specific genes mentioned include Kif3b, ACTB, SRPK1, TM EM 229b, C14orf142, KB-1460A1.5, ACTC1, Nr2f1, KIAA0922, KDELR3, APBA2, miRNA 130b, miRNA 374b, and miRNA 122. These innovative methods aim to improve the accuracy of cancer diagnosis and enhance treatment options for patients.
Career Highlights
Willetts is currently associated with Entos Pharmaceuticals Inc., where she continues to advance her research in cancer treatment. Her work is characterized by a commitment to developing effective therapeutic strategies that can significantly impact patient outcomes.
Collaborations
Willetts collaborates with notable colleagues, including John Lewis and Konstantin Stoletov. These partnerships enhance her research efforts and contribute to the development of groundbreaking medical solutions.
Conclusion
Lian Willetts is a trailblazer in the field of cancer research, with a focus on innovative methods for diagnosing and treating metastatic cancer. Her contributions through her patents and collaborations are paving the way for advancements in medical science.